Medicare Enrolled

Dr. Lin Lemay, M.D.

Neurology · Burbank, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
191 S BUENA VISTA ST, Burbank, CA 91505
8185587888
In practice since 2006 (19 years)
NPI: 1871538686 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lemay from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lemay? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lemay

Dr. Lin Lemay is a neurology specialist in Burbank, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lemay performed 3,508 Medicare services across 1,696 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lemay received a total of $9,317 from 57 pharmaceutical and/or device companies across 370 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lemay is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 17% volume in CA $9,317 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,508
Medicare services
Top 17% in CA for neurology
1,696
Unique beneficiaries
$100
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~185 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
1,527 $99 $400
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
657 $99 $400
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
322 $143 $575
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
296 $86 $200
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
199 $29 $250
Injection of anesthetic or steroid into upper neck and back of head nerve
An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head.
178 $61 $314
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
162 $133 $400
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
75 $219 $575
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
37 $114 $300
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
29 $156 $400
EEG brain wave monitoring, 41-60 minutes
This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes.
26 $46 $700
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,317
Total received (2018-2024)
Avg $1,331/year across 7 years
Top 24% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
370
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,250 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$67 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,001
2023
$1,477
2022
$1,020
2021
$988
2020
$813
2019
$1,454
2018
$1,564

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$576
Neurelis, Inc.
$414
ARGENX US, INC.
$280
Stryker Corporation
$113
Medtronic, Inc.
$112
Novartis Pharmaceuticals Corporation
$93
PFIZER INC.
$81
Genentech USA, Inc.
$66
Baxter Healthcare
$55
Lundbeck LLC
$54
CSL Behring
$54
Grifols USA, LLC
$35
Amgen Inc.
$27
SK Life Science, Inc.
$25
SCILEX PHARMACEUTICALS INC.
$15
Top 3 companies account for 63.5% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,620
Novartis Pharmaceuticals Corporation
$602
Biogen, Inc.
$477
Neurelis, Inc.
$469
AbbVie Inc.
$413
Amgen Inc.
$359
ARGENX US, INC.
$353
Supernus Pharmaceuticals, Inc.
$337
UCB, Inc.
$328
Allergan, Inc.
$282
PFIZER INC.
$264
EMD Serono, Inc.
$239
Teva Pharmaceuticals USA, Inc.
$211
Sunovion Pharmaceuticals Inc.
$204
ACADIA Pharmaceuticals Inc
$188
LivaNova USA, Inc.
$184
W. L. Gore & Associates, Inc.
$179
Lundbeck LLC
$167
Grifols USA, LLC
$166
Acorda Therapeutics, Inc
$163
Allergan Inc.
$140
Medtronic USA, Inc.
$125
Lilly USA, LLC
$121
IDORSIA PHARMACEUTICALS US INC
$121
GENZYME CORPORATION
$116
Stryker Corporation
$113
Medtronic, Inc.
$112
SK Life Science, Inc.
$108
Vertiflex, Inc.
$107
Eisai Inc.
$93
Celgene Corporation
$88
Gilead Sciences, Inc.
$75
Biohaven Pharmaceuticals, Inc.
$71
Genentech USA, Inc.
$66
EISAI INC.
$65
Baxter Healthcare
$55
CSL Behring
$54
E.R. Squibb & Sons, L.L.C.
$54
Assertio Therapeutics, Inc.
$48
Retrophin, Inc.
$42
Bayer HealthCare Pharmaceuticals Inc.
$33
Akcea Therapeutics, Inc.
$31
Sumitomo Pharma America, Inc.
$25
ARBOR PHARMACEUTICALS, INC.
$24
Arbor Pharmaceuticals, Inc.
$23
Alexion Pharmaceuticals, Inc.
$22
MITSUBISHI TANABE PHARMA AMERICA, INC.
$22
Merck Sharp & Dohme Corporation
$21
Scilex Pharmaceuticals Inc.
$20
Horizon Therapeutics plc
$20
Abbott Laboratories
$18
Avion Pharmaceuticals
$17
UPSHER-SMITH LABORATORIES LLC
$17
SCILEX PHARMACEUTICALS INC.
$15
Biohaven Pharmaceutical Holding Company Ltd.
$15
Mylan Pharmaceuticals Inc.
$12
Travere Therapeutics, Inc.
$5
Top 3 companies account for 29.0% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ACTIVA · AIMOVIG · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · BELSOMRA · BOTOX · BOTOX - NEUROLOGY · Balcoltra · Banzel · Betaseron · Briviact · CAMBIA · CARDIOFORM Septal Occluder · COPAXONE · Cholbam · Descovy · EMGALITY · ETERNA · Edarbi · Fycompa · Gamunex-C · Glatiramer Acetate · Gliadel · Gralise · Hizentra · INBRIJA · INSIGNIA · KESIMPTA · LINQ II · LYRICA · MAVENCLAD · MAYZENT · Mavenclad · NUPLAZID · NURTEC ODT · OXTELLAR XR · Ocrevus · PANZYGA · PERCLOT · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · Rebif · SOLIRIS · Superion ISS · TECFIDERA · TEGSEDI · TROKENDI XR · TYSABRI · UBRELVY · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Burbank?
Compare neurologists in the Burbank area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
525
Per 100K population
5.3
County median income
$87,760
Nearest hospital
PROVIDENCE SAINT JOSEPH MEDICAL CTR
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lemay is a clinical cardiology specialist, with above-average Medicare volume (top 17% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lemay experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Lemay performed 1,527 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lemay receive payments from pharmaceutical companies?
Yes. Dr. Lemay received a total of $9,317 from 57 companies across 370 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lemay's costs compare to other neurologists in Burbank?
Dr. Lemay's average Medicare payment per service is $100. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lemay) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →